Figure S4 from A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy

Abstract

Summary of toxicity data from 225Ac SADA-PRIT experiment against a neuroblastoma PDX